Navigation Links
Impact Equalizer 8-Channel Electronic Pipettor, 5-250L

ProductsImpact Equalizer 8-Channel Electronic Pipettor, 5-250L
Company Matrix Technologies Corporation
Item Impact Equalizer 8-Channel Electronic Pipettor, 5-250L
Features 
Description Equally Spaced, Expandable, Multichannel Pipettor

The Equalizer replaces fixed multichannel pipettors and instantly boosts productivity with an industry breakthroughequal tip spacings that expand with the simple adjustment of a slide rod. This innovation allows the quick and easy transfer of liquids between vessels with different configurations.

Adjustable and Equal Tip-To-Tip Spacing
The Equalizers tips can be spaced anywhere from 9mm (microplates) to 14.15mm (12 or 13mm tubes and 48 well plates) in increments of 0.1mm. The distance between tips is always equalsimply set the desired spacing on the scale and pull or push the rod.

No Handling, No Contamination
The unique push/pull rod allows you to spread the tips to your desired spacing without touching the tip fittings. This lessens the possibility of contaminating the tip fittings or samples.

Two Levels of Software
The Equalizer is available with Impact or Impact2 software (see Impact/Impact2) so it can operate at up to five speed settings and is capable of storing up to six 40-step programs.

Simple Calibration
In-lab calibration can be performed quickly and easily. The software provides a trail of calibration information for your lab records.

Long-Lasting, Rechargeable Batteries
Every Equalizer comes with a power supply adapter and a set of NiCad batteries strong enough to deliver a full day of pipetting. The batteries are easy to access so replacement can be done in seconds without any special tools.

Info Matrix Technologies Corporation
Customer Service: (866) 229-9770
Web site: http://www.matrixtechcorp.com/index.aspx

Related medicine products :

1. Tangent Posterior Impacted Instrument Set
2. TANGENT Posterior Impacted Instrument Set
3. Palm Style Impactor Bone Awl
4. Soft Impact Mallet
5. The Impact Walker
6. Micro Impactor
7. Impact Single Channel Pipettor, 5-250L
8. Impact2 Single Channel Pipettor, 5-250L
9. Impact Shorty, 5-250L
10. Impact2 Shorty, 5-250L
11. Impact2 16-Channel Electronic Pipettor, 1.0-30L
... Helmer Platelet Agitators feature ... with non-slip texture coating ... circulation for your platelets. ... to be used in ...
... Helmer platelet agitators offer a wide range ... allow the drawer storage platform to agitate ... which wear down and squeak. Sturdy, one-piece ... uniform air circulation for your platelets., ,i.Series ...
Platelet agitator....
EIA Kit for the detection of progesterone....
Medicine Products:
(Date:7/31/2015)... Chicago, IL (PRWEB) , ... July 31, 2015 , ... ... which is currently going on in Chicago at Grant Park. The festival ... every corner of North America to Chicago for the annual Lollapalooza. This unique ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... run by GoodThreads. The store can be accessed by visiting http://www.curemeso.org/store . ... which are customizable. The best part: whenever a product is purchased, the Meso ...
(Date:7/31/2015)... ... July 31, 2015 , ... There’s no better way to enjoy ... comes time to cook the next meal, making July the most appropriate to be ... grilling tips and recipes. , Make the next cookout different than the ones in ...
(Date:7/31/2015)... ... , ... Coco Libre announced today that their flagship Organic Coconut Water will ... US Open of Surfing, July 25 through August 2 in Huntington Beach, California. Coco ... market, is a natural choice given the Open’s commitment to sustainable practices. , ...
(Date:7/31/2015)... ... 31, 2015 , ... According to the article published July 27 on My News ... contained and extinguished by the city’s fire department before it caused major damage throughout the ... of the fire, and it was a fire alarm system that tipped off fire fighters ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3
... University at Buffalo researcher John Violanti, Ph.D., a ... conduct a study on suicide risk among returning veterans. ... the number of soldiers taking their own lives., Violanti ... how quickly persons associate feelings of self-harm, as a ...
... 6 Masimo Corporation (Nasdaq: MASI ), ... Low-Perfusion pulse oximetry, today announced that its management is ... Annual OC Growth Stock Conference at The Ritz-Carlton, Laguna ... 2009, at 11:00 a.m. PT. A live audiocast of ...
... 6 Optimal Reading Services Group, Inc., ... and radiology group practices, announced that its chief executive ... Global Healthcare Services Conference on Monday, February 9, 2009 ... in New York City.Optimal leverages a deep pool of ...
... Study finds great inactivity and little encouragement for kids ... -- Even when they,re playing outside, children tend not ... says. , In fact, the researchers found that ... 5-year-olds was found to be sedentary at community-based preschool ...
... PA -- For years controversy has surrounded whether electronic ... cut medical errors, and reduce healthcare costs. Now, researchers ... discovered a way to get another bonus from the ... treatments for disease. , In the first ...
... VOLC ), a leader in the development, manufacturing ... coronary and peripheral artery,disease, today announced that it will ... of fiscal 2008 on Tuesday, February 17. , ... call to discuss its financial results,and operating activities open ...
Cached Medicine News:Health News:Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference 2Health News:Optimal Readings to Present at 2009 UBS Global Healthcare Services Conference 2Health News:For Preschoolers, Even 'Play' Tends to Be Sedentary 2Health News:Penn study shows how electronic medical records can be used to test drug efficacy 2Health News:Penn study shows how electronic medical records can be used to test drug efficacy 3Health News:Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast 2
(Date:7/30/2015)... -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ) ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics ... notice it received on May 21, 2015 from the ... was below certain of the Exchange,s continued listing standards, ... the NYSE MKT Company Guide, due to the delay ...
(Date:7/30/2015)... -- Growth of the U.S. nonprescription market is primarily driven ... to the OTC market. Due to an increasingly favorable ... activity over the next five years with several all ... entering the market into existing categories. If ... those with low to moderate likelihood), the market is ...
(Date:7/30/2015)... 30, 2015  Medimetriks Pharmaceuticals, Inc. announced today ... III clinical study for Ozenoxacin, a novel bactericidal ... the exclusive U.S. rights to Ozenoxacin 1% cream.  ... 44 centers with an emphasis on U.S. patients, ... months and older with a clinical diagnosis of ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3